[Prognostic factors for long-term survival in patients with pancreatic ductal adenocarcinoma]

MeSH terms

• CA-19-9 Antigen / blood
• Carcinoma, Pancreatic Ductal / diagnosis*
• Carcinoma, Pancreatic Ductal / mortality
• Carcinoma, Pancreatic Ductal / therapy*
• Combined Modality Therapy
• Humans
• Lymphatic Metastasis
• Neoplasm Staging
• Pancreatic Neoplasms / diagnosis*
• Pancreatic Neoplasms / mortality
• Pancreatic Neoplasms / therapy*
• Prognosis
• Survival Rate